Swedish device developer Enzymatica has named Åsa Anderlind as its new director of quality assurance.
Anderlind joins from QPharma, where she was responsible for GMP training and internal audits. Prior to that role she served as quality assurance director at Euro Diagnostica and Wieslab. She previously held various QA positions at BioInvent, Ferring and Biopool.
Enzymatica develops and sells medical devices for infection-related diseases, such as the ColdZyme mouth spray. The products are based on a barrier technology that includes marine enzymes.